SurePath AI, Inc.

Based in Denver, US, and founded in 2023 by co-founders Casey Bleeker (CEO) and Randy Birdsall (CPO), SurePath AI, Inc. operates as a provider of a GenAI governance platform that ensures secure usage, mitigates risks, and monitors enterprise data for businesses adopting generative AI solutions. In May 2024, SurePath AI, Inc. raised USD 5.

2 million in seed funding led by Uncork Capital, with participation from Operator Collective. SurePath AI provides a GenAI governance platform intended to govern the use of Generative AI (GenAI) within enterprises. The platform focuses on detecting GenAI usage, mitigating associated risks, and controlling access to sensitive enterprise data. Key functionalities include recording all GenAI interactions, generating audit trails for monitoring purposes, and detecting and redacting sensitive information to ensure secure outputs.

The system allows enterprises to sync group memberships to manage role-based data access and empowers administrators to enforce granular access policies. SurePath AI primarily targets organizations across various industries seeking to adopt GenAI safely, with its solutions available in key markets such as North America and Europe. The revenue model of SurePath AI is structured around subscription-based transactions, where clients pay for access to its platform and services. Clients typically enter into agreements that grant them access to the GenAI governance tools, which include features like audit trails, data protection mechanisms, and customization options for organizational needs.

The company offers various pricing plans tailored to different sizes of organizations, including small businesses and large enterprises, each designed to meet specific needs related to GenAI adoption and governance. The company aims to expand its geographic presence by entering markets in Asia and Latin America by mid-2025.